BioSpace News Archive

The American Brachytherapy Society (ABS) supports the continued utilization of HDR GYN Brachytherapy in the curative treatment of non-operable, locally advanced cervical cancer.

PharmaCyte Biotech (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully completed a U.S. Food and Drug Administration (FDA) required formal report on the safety studies conducted by Bavarian Nordic

HealthCare.com a leading direct-to-consumer health insurance company, today announced it ranked #92 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America.

Pulmatrix. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases will present the results of the recently completed phase 1/1b clinical trial of Pulmazole, an inhaled dry-powder iSPERSE™ formulation of itraconazole, at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology in Seattle, Washington on November 17, 2018.

The researchers found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, those with intermediate tumor grade, the uninsured, and those treated at NCI-designated centers

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced that data from the dose escalation portion of its Phase 1 trial of SY-1365, its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor, demonstrated proof-of-mechanism at tolerable doses in patients with advanced solid tumors.

Donations will support local American Red Cross chapters, North Valley Community Foundation and Los Angeles Fire Department Foundation

Upon analyzing the accumulated evidence that microbes inhabit or visit the brain and likely trigger Alzheimer’s disease, Leslie Norins, MD, PhD, concluded, “The suspects have been reliably placed at the crime scene.” Dr. Norins is CEO of Alzheimer’s Germ Quest, Inc., an independent advocacy group for Alzheimer’s research.

SoClean, the CPAP sanitizing device company, today announced that it has been named by Deloitte as one of America’s fastest growing technology companies.

FUJIFILM Medical Systems U.S.A.,Inc. will present, REiLI,* the company’s global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative at the Radiological Society of North America’s (RSNA) annual meeting to be held from November 25-30, 2018 at McCormick Place in Chicago, IL.